StreetAlpha.app
Home › Stocks › AEON

AEON Biopharma, Inc. (AEON)

$0.12
▼ −7.59%
LAST CLOSE · NOV 20

AEON Biopharma is developing ABP-450, a botulinum toxin meant to be a biosimilar to Botox for therapeutic uses. It last closed at $0.12 on Nov 20, down 7.59% on the day. The next earnings report for AEON is expected around Mon, Mar 29, 2027, after the close. For the quarter ended Sep 2026, AEON reported EPS of $0.01. Over its last 8 reports the stock moved an average of 7.4% the session after earnings. Over the last 12 months AEON insiders bought $301K of stock on the open market and sold $0, according to SEC Form 4 filings.

AI Auto Pilots
Is AEON in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold AEON.

Key Stats

Last 12 months
Results
Net income
−$47.6M
Valuation
Market cap
$10.3M
84.1M shares
P/E
–
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$11.4M
At Sep 30
Debt
$2.0M
At Sep 30
Shareholder equity
$2.4M
Shares outstanding
84.1M
At Nov 13
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $8.2M$8.2MFY2021FY2022: −$52.6M−$52.6MFY2022FY2024: $42.0M$42.0MFY2024FY2025: −$39.2M−$39.2MFY2025

From AEON's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 16). Last 12 months adds up the four latest quarters.

Next report
Mar 29
Estimated date · After the close
Reported EPS
$0.01
Quarter ended Sep 2026
Year ago EPS
-$0.39
Same quarter last year
Revenue
—
Last reported quarter
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $3.40Dec '24Mar 2025: $2.28Mar '25Jun 2025: -$0.60Jun '25Sep 2025: -$0.39Sep '25Dec 2025: -$3.72Dec '25Mar 2026: -$0.29Mar '26Jun 2026: -$0.02Jun '26Sep 2026: $0.01Sep '26Latest $0.01
Revenue by quarter
Not enough quarters on file yet.
How AEON moved after its last 8 reports
Average move the session after a report ±7.4%
Nov 16, 2026After the close−19.4%
Aug 12, 2026After the close−1.6%
May 14, 2026After the close−9.9%
Mar 30, 2026After the close−0.5%
Nov 14, 2025Time not announced−3.8%
Aug 12, 2025After the close+16.1%
May 14, 2025After the close−1.0%
Mar 24, 2025After the close−7.3%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on AEONStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on AEON
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on AEON

Technical Analysis

AEON · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold

The stock is 56% below its 20 day and 89% below its 50 day average. It is 389% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 32), near oversold. The nearest support is the Pivot S1 at $0.12, and the nearest resistance the Pivot at $0.13.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 22.6%/day
Key levels
$1.4552 week high+1108.3%
$0.60200 day average+400.0%
$0.27100 day average+125.0%
$0.25Swing high (Oct 21)+108.3%
$0.2350 day average+91.7%
$0.1920 day average+58.3%
$0.13Pivot R1+8.3%
$0.13Pivot+8.3%
$0.12Pivot S1+0.0%
$0.12Last close
$0.1152 week low−8.3%
$0.11Swing low (Nov 17)−8.3%
Indicators
RSI (14)31.51Weak, oversold below 30Neutral
MACD-0.03Below its signal lineBearish
Stochastic11.1Near the bottom of its rangeOversold
ADX (14)31.2Trending down
Williams %R-90.0Oversold below −80, overbought above −20Oversold
CCI (20)-93.5Oversold below −100, overbought above 100Neutral
Rate of change−30.1%Change over 10 sessionsBearish
ATR (14)$0.03Typical daily range, 22.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for AEON

What happened before

See how AEON did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow AEON usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How AEON has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2023.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for AEONHow many large options trades hit AEON, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

AEON Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲13 buying vs 5 selling
  • ▲Held by funds +58.8 pts
  • ▲Funds holding +6
  • ▲Superinvestors: 1 added, 0 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding2822+27.3%
In funds' top 10110.0%
Held by funds74.0%15.2%+58.8 pts
New / increased10 / 32 / 6+62.5%
Reduced / sold out1 / 41 / 40.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See AEON institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AEON Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$301K4 buys · 4 insiders
Sold$00 sales · 0 insiders
Cluster buy: 3 insiders bought $57K between Nov 19 and Nov 20.
2026-08 bought $243K2026-11 bought $57KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 20Alexander Blair WilsonCLO, CSO and Corp SecretaryBuy135,706$0.13$17K
Nov 19Jennifer SyChief Accounting OfficerBuy153,846$0.13$20K
Nov 19Robert E. BancroftPresident and CEOBuy152,333$0.13$20K
Aug 19Timothy P Lynch10% ownerBuy1,150,000$0.21$243K
May 21, 2025Jost FischerDirectorBuy60,000$0.49$29K
May 20, 2025Jost FischerDirectorBuy110,000$0.51$56K
Every insider buy and sale for AEON over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See AEON insider trades →

From SEC Form 4 filings by AEON's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AEON is in one of them and how their past AEON trades turned out.

AEON in the AI portfolios
Loading…

AEON News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered AEON in an article yet. Here's the latest on the wider market.

AEON in the news

About AEON Biopharma

AEON Biopharma is a biopharmaceutical company based in Aliso Viejo, California. It is developing ABP-450, a botulinum toxin intended to serve as a biosimilar to Botox for therapeutic medical uses rather than cosmetic ones. The product is still in development, and the company is working toward a regulatory filing in the United States. Its intended customers are physicians and patients who use botulinum toxin treatments for medical conditions.

Headquarters
Aliso Viejo, CA